Chronic Pain Clinical Trial
Official title:
Use of Wearable Tech to Increase Physical Activity in Inpatient Rehabilitation for Patients With Chronic Pain
Verified date | January 2020 |
Source | Norwegian University of Science and Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this project is to evaluate whether use of wearable tech increases levels of physical activity in patients participating in inpatient rehabilitation for chronic pain.
Status | Completed |
Enrollment | 44 |
Est. completion date | January 14, 2020 |
Est. primary completion date | January 14, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - taking part in inpatient rehabilitation at Unicare Helefort Rehabilitation center for chronic pain. Exclusion Criteria: - not having a smartphone (will not be able to access the mobile application). - using a wheelchair (the technology will be not able to measure activity correctly) |
Country | Name | City | State |
---|---|---|---|
Norway | Unicare Helsefort | Rissa |
Lead Sponsor | Collaborator |
---|---|
Norwegian University of Science and Technology |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Activity level | Time spent in moderate to vigorous physical activity (minutes per day) | 2 weeks (time period at home between two stays at the rehabilitation center) | |
Primary | Number of PAIs | mean number of Personal Activity Intelligence (PAI) points achieved per week | 2 weeks (time period at home between two stays at the rehabilitation center) | |
Primary | Percentage achieving 100 PAIs per week | Personal Activity Intelligence (PAI) | 2 weeks (time period at home between two stays at the rehabilitation center) | |
Secondary | oxygen uptake | submaximal oxygen uptake measured by the Åstrand bicycle test (described in Textbook of work physiology by Astrand from 1986) | 6 weeks (from inclusion to end of rehabilitation program) | |
Secondary | Anxiety and depression symptoms | HSCL-25 questionnaire | 6 weeks (from inclusion to end of rehabilitation program) | |
Secondary | Average pain | Visual Analogue Scale (VAS). VAS is a straight horizontal line where the ends are defined as the extreme limits from the left (0-no pain) to the right (100-worst imaginable pain). The patient is asked to mark his pain level on the line between the two endpoints. The distance between 'no pain at all' and the mark then defines the subject's pain. | 6 weeks (from inclusion to end of rehabilitation program) | |
Secondary | Health related quality of life | EQ5D questionnaire | 6 weeks (from inclusion to end of rehabilitation program) | |
Secondary | Body weight | body weight in kilograms | 6 weeks (from inclusion to end of rehabilitation program) | |
Secondary | Body Mass Index score | weight in kilograms divided by height in metres squared | 6 weeks (from inclusion to end of rehabilitation program) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|